Alexandra Fedorova

Dr. Alexandra Fedorova

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
EZEkaterina Zelenova
Ekaterina Zelenova
TBTatiana Belysheva
Tatiana Belysheva
ESElena Sharapova
Elena Sharapova
IBIrina Barinova
Irina Barinova
AFAlexandra Fedorova
Alexandra Fedorova
TNTatiana Nasedkina
Tatiana Nasedkina
Background/Objectives: Cowden syndrome (or PTEN hamartoma tumor syndrome) (CS/PHTS) belongs to a group of inherited disorders associated with the development of multiple hamartomas. The clinical presentation of patients may include dysmorphic facial features, macrocephaly, developmental delay, and multiple benign and malignant tumors of various localizations. At the same time, only thyroid cancer is thought to have an increased risk in childhood. Skin lesions in CS/PHTS occur in 90–100% of patients and include multiple tricholemmoma, papilloma, acral keratosis, pigmentation changes, as well as rarer forms like vascular malformations, fibromas, neuromas, melanoma, and basal cell carcinoma. Methods: Next-generation sequencing and Sanger sequencing were used to search for PTEN genetic variants. A histological and immunohistochemical examination of tumor biopsies and skin lesions was performed. Results: A total of 13 patients from six families with CS/PHTS, including 10 children, were described. Seven pediatric patients belonged to families with paternal transmission of the PTEN pathogenic variants, while three others were de novo cases. Atypical manifestations in CS/PHTS were diffuse large B-cell lymphoma in one adult, a renal cell carcinoma, three germ cell tumors, and a linear epidermal nevus in pediatric patients. A literature review of the identified pathogenic variants in the PTEN gene was performed, assessing their clinical significance and analyzing the traditional and modified diagnostic criteria as applied to the pediatric population. Conclusions: Taking into account the low incidence of CS/PHTS, the data presented significantly expand our current understanding of this disease and guide physicians to consider a wider range of possible malignant neoplasms in pediatric patients with CS/PHTS.

20 December 2022 in Bone and soft tissue sarcomas, tumors of the skin
Verified
Journal Article
Open access
PDF file
VSV. A. Sokolovskii
V. A. Sokolovskii
ASA. V. Sokolovskii
A. V. Sokolovskii
ATAnastasia Tararykova
Anastasia Tararykova
AFAlexandra Fedorova
Alexandra Fedorova
ABA. B. Bludov
A. B. Bludov
Introduction. Primary malignant tumors of the skeletal system mostly develop in young and middle-aged people. Morbidity in this age group amounts to between 75 and 80 % of overall morbidity. Due to low survival caused by patient death in the first 5 years mostly because of metastases of primary malignant tumors, the main focus of treatment was on prolongation of life, study and development of new methods of conservative therapy. Therefore, until the early 1970 amputation surgery was the generally accepted standard of surgical intervention. Positive oncological results required revision of the surgical concept of treatment in this patient group. This problem was solved through active development of oncological endoprosthesis started in the second half of the 1970s and led to shaping of orthopedic oncology into a separate oncological specialty. The study objective is to study long-term oncological results of treatment of patients with primary and metastatic tumors of the locomotor system after oncological endoprosthesis. Materials and methods. The study included 1292 patients with primary sarcomas of the bones, soft tissues and patients with metastatic and benign bone tumors who underwent 1200 bone resections/extirpations of varying scale with endoprosthetic replacement between January of 1992 and January of 2020. In the total group of patients who underwent endoprosthesis, the number of men and women was approximately the same: 677 (52.4 %) and 615 (47.6 %), respectively. At the time of surgery, age of the patients in the total group varied between 10 and 81 years. Mean patient age was 34.7 years. Most commonly, endoprosthetic replacement was performed in patients between the ages of 21 and 30 years (in 29 % of cases). Oncological endoprosthesic replacement was performed in 814 (67.8 %) patients with primary malignant tumors, 143 (11.9 %) patients with metastatic lesions in long bones, and 243 (20.3 %) patients with benign neoplasms. Mean follow-up period after endoprosthesis of different bone segments was 82.8 months (between 0 and 335.7 months). Results. In 27 years of observations, total frequency of recurrences after endoprosthesis for various tumor locations (type V complication per the International Society of Limb Salvage system (2013) (ISOLS 2013)) was 8.8 % (86/979); among them recurrence in the bone (type VA complication) was observed in 1.7 % (17/979) of cases, recurrence in the soft tissues (type VB complication) in 7.0 % (69/979) of cases. Primary endoprosthetic replacement due to recurrence after previous surgical treatment leads to 2.2-time increase in the risk of development of this complication. The obtained results show that repeat recurrence significantly increases the risk of recurrence in soft tissues and does not affect the risk of recurrence in the bone. The most recurrences developed in patients with non-differentiated pleomorphic sarcoma (15.4 % of cases), chondrosarcoma (15.0 % of cases) and parosteal osteosarcoma (14.3 % of cases). Frequency of recurrences in patients with giant cell bone tumors and aneurysmal bone cysts was 4.0 and 3.8 %, respectively. In cases of tumor recurrence after endoprosthesis, limb amputation was the most common treatment: 33.7 % (28/83) of cases. In this study, recurrence mostly developed after femur resection with knee joint endoprosthesis: in 45.8 % (38/83) of cases. Frequency of oncological complications in patients with bone sarcomas who underwent endoprosthetic replacement was 31.9 % (283/886). In the total patient group in 27 years of observations, in 25.3 % (224/886) of patients disease progression in the form of metastases was observed. Local tumor recurrence was accompanied by metastases in 6.7 % (59/886) of cases. Conclusion. Decreased risk of development of local recurrences depends on the effectiveness of complex approach to therapy in this disease group. Changes in surgical endoprosthesis techniques in tumors of varying differentiation levels allowed to achieve significant radicalness of treatment. Progression risk for bone sarcomas, level of response to specialized therapy and, as a result, patient’s prognosis depend on the presence of epigenetic, genetic, molecular and chromosomal abnormalities.

13 April 2022 in Bone and soft tissue sarcomas, tumors of the skin
Verified
Journal Article
Open access
PDF file
ASA. V. Sokolovskii
A. V. Sokolovskii
VSV. A. Sokolovskii
V. A. Sokolovskii
ABA. B. Bludov
A. B. Bludov
AFAlexandra Fedorova
Alexandra Fedorova
DAD. K. Agaev
D. K. Agaev
АVА. K. Valiev
А. K. Valiev
Introduction.The results of using various reconstructive technologies in the 1980–1990’s to replace post-resection bone defects determined oncological endoprosthetics as the most promising onco-orthopedics trend, due to the quality-of-life and functional potential restoration in a short time. Despite the constant improvement of the design and technology of oncological endoprosthesis at the moment, complications such as aseptic instability, mechanical failure and infection of the endoprosthesis significantly affect the reduction of implant survival. It is impossible to reduce the frequency of endoprosthesis aseptic instability without developing a unified strategy for the prevention and treatment of this type of complication.The study objective – to examine the main causes of early and late aseptic loosening, analyze complication rate in various periods after endoprosthesis using literature data and results of treatment of a large patient group who underwent primary and repeat endoprosthesis for different post-resection bone defects.Materials and methods. The study included 1292 patients aged 10 to 81 years with primary bone and soft tissues sarcomas, metastatic, benign lesions of the bone, who since January 1992 to January 2020 were performed 1671 primary and revision endoprosthetics of various bone segments. The age of the patients ranged from 10 years to 81 years. The mean age of the patients was 34.7 years. In the study group of patients, most often endoprosthetics was performed at the age of 21 to 30 years and accounted for 29 % of cases. The mean follow-up period after primary arthroplasty of various segments was 82.8 months (from 0 to 335.7 months). The mean follow-up period after revision arthroplasty was 54.2 months (from 0 to 282.8 months). In 1594 (95.4 %) cases were used bone cement stem fixation.Results. The results of the study show that the optimal shape of the endoprosthesis stem for primary and revision endo-prosthesis replacement is conical and cylindrical figured (made in the shape of the bone marrow canal). The most stable endoprosthesis stems are 60–100 mm long for upper limb arthroplasty and 110–150 mm for lower limb arthroplasty. Endoprosthesis stems longer than 160 mm can only be used in revision endoprosthetics. The length of the bone resection does not affect the incidence of endoprosthesis instability. The quality of the formed cement mantle affects the frequency of endoprosthesis instability. The presence of at least one revision arthroplasty with replacement of the endoprosthesis stem increases the risk of developing subsequent early instability (type IIA) about 4 times and the risk of late instability (type IIB) about 6 times compared with primary arthroplasty. The occurrence of late aseptic instability of the endoprosthesis (type IIB) will lead to the development of breakage/destruction of the endoprosthesis (type IIIA) in a shorter period than the breakage/ destruction of the endoprosthesis will lead to the development of late instability of the endoprosthesis (type IIB).Conclusion. The choice of an endoprosthesis, taking into account the optimal biomechanics of the endoprosthesis design, the shape of the stem, methods of fixation, the introduction of innovative technological solutions, adherence to the principles of oncological endoprosthesis replacement, is a means of reducing the incidence of this type of complications.

30 September 2020 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
NKN. V. Kochergina
N. V. Kochergina
SPS. N. Prokhorov
S. N. Prokhorov
ABA. B. Bludov
A. B. Bludov
ARA. D. Ryzhkov
A. D. Ryzhkov
AFAlexandra Fedorova
Alexandra Fedorova
OSO. G. Spirina
O. G. Spirina
Эффективность МРТ в уточнении наличия метастазов в кости при спорном результате ОФЭКТ/КТ

1 July 2023 in Bone and soft tissue sarcomas, tumors of the skin
Verified
Journal Article
Open access
PDF file
AGA. M. Galustov
A. M. Galustov
Denis SofronovDenis Sofronov
Denis Sofronov
NKN. A. Kozlov
N. A. Kozlov
AFAlexandra Fedorova
Alexandra Fedorova
GBG. S. Batyrova
G. S. Batyrova
KBK. A. Borzov
K. A. Borzov
Intriduction. Hibernomas account for less than 2 % of all benign lipomatous tumors and 1 % of all lipomatous tumors. They are usually found in 20–40-year old adults (the average age of patients is 38 years). The clinical manifestations are painless soft tissue mass that are mostly slow growing; rapid growth is only found in a small number of patients. We present a case of successful surgical treatment of a pathologically confirmed rare lipomatous tumor of large size, which was located in the soft tissues of the thigh.Clinical case. A 46-year-old woman was admitted to the hospital due to a tumor 20 × 10 × 10 cm in size, that had developed 10 years ago in the anteromedial aspect of the proximal thigh. Furthermore, she had a history of hypoesthesia one month prior to her admission. During surgery, the femoral nerve was found to be compressed by the large tumor. The resultant symptoms probably caused the patient to seek medical care. Resection was performed by careful dissection, femoral nerve and vessels were spared. Histopathological examination and cytogenetics showed findings suggestive of a hibernoma. At the 6-month follow-up local tumor recurrence or metastasis was not found.Conclusions. Asymptomatic small-sized hibernoma does not require surgical resection or other treatment. When the tumor is too large and/or has the potential to compress the surrounding tissues, timely radical surgical intervention is reuired.

29 September 2018 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
AFAlexandra Fedorova
Alexandra Fedorova
NKN. V. Kochergina
N. V. Kochergina
IBI. V. Boulytcheva
I. V. Boulytcheva
ESE. A. Sushentsov
E. A. Sushentsov
ANA. S. Nered
A. S. Nered
ЯЩЯ. А. Щипахина
Я. А. Щипахина
Chondrosarcoma is one of the most common tumors in adults. Correct grading of chondrosarcoma is the most important criterion that defines the course of surgical treatment. A case report of a 56 years old female patient with chondrosarcoma of the pelvic bone is presented. The assistance of magnetic resonance tomography in accurate grading of the tumor is shown.